Differences in acute kidney injury ascertainment for clinical and preclinical studies.

about

Definition, Management, and Outcomes of Acute Kidney Injury: An International Survey of Nephrologists.

P2860

Q48516141-C99436B5-1C0C-421D-82B8-C2DDD811A0CF

P2860

Differences in acute kidney injury ascertainment for clinical and preclinical studies.

Item

http://www.wikidata.org/entity/Q39216951

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Differences in acute kidney injury ascertainment for clinical and preclinical studies.

@en

Differences in acute kidney injury ascertainment for clinical and preclinical studies.

@nl

type

Item

label

Differences in acute kidney injury ascertainment for clinical and preclinical studies.

@en

Differences in acute kidney injury ascertainment for clinical and preclinical studies.

@nl

prefLabel

Differences in acute kidney injury ascertainment for clinical and preclinical studies.

@en

Differences in acute kidney injury ascertainment for clinical and preclinical studies.

@nl

P1476

Differences in acute kidney injury ascertainment for clinical and preclinical studies

@en

P2093

Giuseppe Castellano

http://www.w3.org/2001/XMLSchema#string

John A Kellum

http://www.w3.org/2001/XMLSchema#string

P2860

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Effects of valproic acid and dexamethasone administration on early bio-markers and gene expression profile in acute kidney ischemia-reperfusion injury in the rat

Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats

Targeting Endogenous Repair Pathways after AKI.

Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI

Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments.

Renal Hemodynamics in AKI: In Search of New Treatment Targets.

Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.

Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process.

Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety

P304

1789-1805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFX002

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marco Fiorentino

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28371878

http://www.w3.org/2001/XMLSchema#string

Differences in acute kidney injury ascertainment for clinical and preclinical studies.

about

P2860

P2860

Differences in acute kidney injury ascertainment for clinical and preclinical studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698